Dolby Laboratories (DLB) Stock Analysis
Falling Knife setup
Industrials · Specialty Business Services
Sell if holding. Momentum 1.7/10 is below the 5.0 floor at $54.21 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Product: Licensing (93.0%); Sector modifier (Industrials): -0.7.
Dolby Laboratories licenses audio and video technologies (DD+, Dolby Atmos, Dolby Vision, patent pools) to ~1,000 device manufacturers globally and sells cinema hardware and services to exhibitors. Licensing generates 93% of revenues with broadcast (34%), mobile (22%), CE (12%),... Read more
Sell if holding. Momentum 1.7/10 is below the 5.0 floor at $54.21 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Product: Licensing (93.0%); Sector modifier (Industrials): -0.7. Chart setup: Death cross, below all MAs, RSI 23, MACD bearish. Score 5.3/10, high confidence.
Passes 7/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 80d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.
Recent Developments — Dolby Laboratories
Latest news
- Vest Financial LLC Increases Stock Holdings in Dolby Laboratories $DLB - MarketBeat — MarketBeat positive
- Dolby Laboratories (DLB) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory — StockStory neutral
- Dolby Laboratories (DLB) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail — The Globe and Mail neutral
- Dolby Laboratories (DLB) Enhances BMW 7 Series with Dolby Atmos Audio - GuruFocus — GuruFocus positive
- Boston Trust Walden Corp Has $56.85 Million Stake in Dolby Laboratories $DLB - MarketBeat — MarketBeat neutral
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Concentration Risks(10-K Item 1A)
- HIGHProductLicensing93%10-K Item 1: 'Licensing ... 93%... Products and services ... 7%... Total ... 100%'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 1.7/10 is below the 5.0 floor at $54.21 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Product: Licensing (93.0%); Sector modifier (Industrials): -0.7. Chart setup: Death cross, below all MAs, RSI 23, MACD bearish. Prior stop was $51.85. Score 5.3/10, high confidence.
Take-profit target: $66.58 (+22.8% upside). Prior stop was $51.85. Stop-loss: $51.85.
Concentration risk — Product: Licensing (93.0%); Sector modifier (Industrials): -0.7; Leverage penalty (D/E 1.9): -1.0.
Dolby Laboratories trades at a P/E of 21.5 (forward 11.8). TrendMatrix value score: 6.6/10. Verdict: Sell.
11 analysts cover DLB with a consensus score of 4.0/5. Average price target: $78.
What does Dolby Laboratories do?Dolby Laboratories licenses audio and video technologies (DD+, Dolby Atmos, Dolby Vision, patent pools) to ~1,000...
Dolby Laboratories licenses audio and video technologies (DD+, Dolby Atmos, Dolby Vision, patent pools) to ~1,000 device manufacturers globally and sells cinema hardware and services to exhibitors. Licensing generates 93% of revenues with broadcast (34%), mobile (22%), CE (12%), and PC (12%) as primary end markets. Revenue is predominantly royalty-based per-unit arrangements.